We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
176
Wolverine Asset Management
Illinois
– -$3.81M -82,346 Closed
JG
177
Jefferies Group
New York
– -$3.74M -80,696 Closed
FIA
178
FNY Investment Advisers
New York
– -$3.62M -78,150 Closed
Walleye Trading
179
Walleye Trading
New York
– -$3.62M -78,038 Closed
WRBC
180
W.R. Berkley Corp
Connecticut
– -$3.57M -77,048 Closed
AI
181
Axiom Investors
Connecticut
– -$3.47M -74,885 Closed
BCM
182
Beryl Capital Management
California
– -$3.41M -73,531 Closed
CIP
183
Chartwell Investment Partners
Pennsylvania
– -$3.31M -71,475 Closed
Fiera Capital (Canada)
184
Fiera Capital (Canada)
Quebec, Canada
– -$3.3M -71,142 Closed
SO
185
STRS Ohio
Ohio
– -$3.27M -70,700 Closed
MLICM
186
Metropolitan Life Insurance Company (MetLife)
New York
– -$3.19M -68,923 Closed
WBC
187
Westpac Banking Corp
Australia
– -$3.11M -67,064 Closed
BNP Paribas Financial Markets
188
BNP Paribas Financial Markets
France
– -$3.04M -65,510 Closed
GH
189
GAM Holding
Switzerland
– -$2.94M -63,420 Closed
MS
190
Maven Securities
Jersey
– -$2.82M -61,000 Closed
FP
191
Foundry Partners
Minnesota
– -$2.59M -55,986 Closed
Jane Street
192
Jane Street
New York
– -$2.55M -54,982 Closed
KPF
193
K2 Principal Fund
Ontario, Canada
– -$2.53M -54,539 Closed
PP
194
Paloma Partners
Connecticut
– -$2.51M -54,202 Closed
DCM
195
Dupont Capital Management
Delaware
– -$2.35M -50,612 Closed
PMFA
196
Plante Moran Financial Advisors
Michigan
– -$2.33M -50,177 Closed
Mirae Asset Global Investments
197
Mirae Asset Global Investments
South Korea
– -$2.32M -50,057 Closed
LOAMU
198
Lombard Odier Asset Management (USA)
New York
– -$2.32M -50,000 Closed
VCM
199
Voleon Capital Management
California
– -$2.32M -50,000 Closed
Creative Planning
200
Creative Planning
Kansas
– -$2.29M -49,508 Closed
6 7
8
9 10

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.